Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted therapy for rare lung cancers: Status, challenges, and prospects
Chunsen Wang, Xiang Yuan, Jianxin Xue
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1960-1978
Open Access | Times Cited: 10

Showing 10 citing articles:

The interplay between gut bacteria and targeted therapies: implications for future cancer treatments
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Mutational landscapes of brain metastases across various histological subtypes of lung cancer
Marcin NicoĊ›, Tomasz Stokowy, Katarzyna Reszka, et al.
Research Square (Research Square) (2025)
Closed Access
YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway
Hongmei Zheng, Yaoxiang Tang, Hongjing Zang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Comprehensive Pan-cancer Analysis Revealed CASP10 As a Promising Biomarker For Diverse Tumor Types
Qian Wang, Yaping Jiang, Weijia Liao, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies
Eupa Ray, Krishna Jadhav, Monika Kadian, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 38, pp. 9740-9759
Closed Access | Times Cited: 3
Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis
Caiyan Jia, Qian Xu, Lu Zhao, et al.
Translational Oncology (2023) Vol. 39, pp. 101832-101832
Open Access | Times Cited: 5
Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics
Hui Li, Xinyan Dai, Jun-Fu Zhou, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 11
Closed Access | Times Cited: 1
Case report: Fatal hemoptysis after effective treatment with tislelizumab and anlotinib in pulmonary sarcomatoid carcinoma
Chen-Wei Pu, Yong-Fen Ma, Jingjing Peng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Epstein-Barr Virus BARF1 Is Expressed in Lung Cancer and Is Associated with Cancer Progression
Julio Osorio, A. Armijo, Francisco J. Carvajal, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1578-1578
Open Access
Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study
Jialong Li, Youyu Wang, Ze-Rui Zhao, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 12, pp. 3344-3351
Open Access
Page 1

Scroll to top